Aquestive Therapeutics Stock Price History
| AQST Stock | USD 4.51 0.23 4.85% |
Below is the normalized historical share price chart for Aquestive Therapeutics extending back to July 25, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aquestive Therapeutics stands at 4.51, as last reported on the 21st of November, with the highest price reaching 4.69 and the lowest price hitting 4.44 during the day.
If you're considering investing in Aquestive Stock, it is important to understand the factors that can impact its price. Currently, Aquestive Therapeutics is relatively risky. Aquestive Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0247, which signifies that the company had a 0.0247% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aquestive Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Aquestive Therapeutics' Downside Deviation of 4.13, risk adjusted performance of 0.0482, and Mean Deviation of 3.43 to double-check if the risk estimate we provide is consistent with the expected return of 0.1%.
Liabilities And Stockholders Equity is likely to gain to about 66.8 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (101.2 M). . At this time, Aquestive Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.18 in 2024, despite the fact that Price To Operating Cash Flows Ratio is likely to grow to (18.42). Aquestive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of July 2018 | 200 Day MA 3.9214 | 50 Day MA 4.9956 | Beta 2.816 |
Aquestive |
Sharpe Ratio = 0.0247
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | AQST | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Aquestive Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aquestive Therapeutics by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (1.81) | Price Sales 7.4614 | Shares Float 80.1 M | Wall Street Target Price 10.0625 | Earnings Share (0.45) |
Aquestive Therapeutics Stock Price History Chart
There are several ways to analyze Aquestive Stock price data. The simplest method is using a basic Aquestive candlestick price chart, which shows Aquestive Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 29, 2024 | 5.66 |
| Lowest Price | September 6, 2024 | 4.18 |
Aquestive Therapeutics November 21, 2024 Stock Price Synopsis
Various analyses of Aquestive Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aquestive Stock. It can be used to describe the percentage change in the price of Aquestive Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aquestive Stock.| Aquestive Therapeutics Accumulation Distribution | 67,385 | |
| Aquestive Therapeutics Price Rate Of Daily Change | 0.95 | |
| Aquestive Therapeutics Price Action Indicator | (0.17) | |
| Aquestive Therapeutics Price Daily Balance Of Power | (0.92) |
Aquestive Therapeutics November 21, 2024 Stock Price Analysis
Aquestive Stock Price History Data
The price series of Aquestive Therapeutics for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 1.48 with a coefficient of variation of 7.32. The prices are distributed with arithmetic mean of 4.86. The median price for the last 90 days is 4.86.| Open | High | Low | Close | Volume | ||
| 11/21/2024 | 4.74 | 4.69 | 4.44 | 4.51 | 1,264,144 | |
| 11/20/2024 | 4.81 | 4.88 | 4.64 | 4.74 | 1,274,283 | |
| 11/19/2024 | 4.54 | 4.84 | 4.45 | 4.82 | 1,061,921 | |
| 11/18/2024 | 4.45 | 4.66 | 4.36 | 4.64 | 1,454,983 | |
| 11/15/2024 | 4.60 | 4.60 | 4.40 | 4.44 | 1,626,197 | |
| 11/14/2024 | 4.83 | 4.86 | 4.52 | 4.57 | 2,184,961 | |
| 11/13/2024 | 5.01 | 5.14 | 4.82 | 4.83 | 1,048,963 | |
| 11/12/2024 | 5.04 | 5.25 | 4.88 | 4.99 | 1,482,879 | |
| 11/11/2024 | 5.54 | 5.59 | 4.92 | 5.07 | 2,573,132 | |
| 11/08/2024 | 5.10 | 5.51 | 4.98 | 5.46 | 1,741,854 | |
| 11/07/2024 | 5.02 | 5.25 | 4.87 | 5.08 | 1,407,122 | |
| 11/06/2024 | 4.98 | 5.19 | 4.83 | 5.07 | 1,947,766 | |
| 11/05/2024 | 5.00 | 5.12 | 4.62 | 4.76 | 3,477,728 | |
| 11/04/2024 | 5.50 | 5.52 | 5.12 | 5.15 | 2,016,300 | |
| 11/01/2024 | 5.60 | 5.67 | 5.45 | 5.52 | 1,317,489 | |
| 10/31/2024 | 5.67 | 5.67 | 5.38 | 5.49 | 1,388,276 | |
| 10/30/2024 | 5.64 | 5.80 | 5.48 | 5.64 | 1,764,731 | |
| 10/29/2024 | 5.50 | 5.67 | 5.38 | 5.66 | 1,219,057 | |
| 10/28/2024 | 5.59 | 5.70 | 5.38 | 5.49 | 1,822,943 | |
| 10/25/2024 | 5.56 | 5.57 | 5.37 | 5.49 | 1,551,694 | |
| 10/24/2024 | 5.39 | 5.73 | 5.26 | 5.48 | 2,293,514 | |
| 10/23/2024 | 5.05 | 5.42 | 5.02 | 5.37 | 1,593,691 | |
| 10/22/2024 | 4.89 | 5.11 | 4.89 | 5.10 | 676,041 | |
| 10/21/2024 | 5.01 | 5.03 | 4.69 | 4.95 | 1,434,971 | |
| 10/18/2024 | 4.94 | 5.30 | 4.94 | 5.03 | 1,941,058 | |
| 10/17/2024 | 4.90 | 5.00 | 4.85 | 4.92 | 600,870 | |
| 10/16/2024 | 4.92 | 5.00 | 4.82 | 4.93 | 656,860 | |
| 10/15/2024 | 4.81 | 5.04 | 4.74 | 4.89 | 1,298,363 | |
| 10/14/2024 | 4.93 | 4.93 | 4.79 | 4.84 | 676,138 | |
| 10/11/2024 | 4.68 | 4.91 | 4.64 | 4.89 | 792,207 | |
| 10/10/2024 | 4.67 | 4.85 | 4.57 | 4.70 | 1,154,640 | |
| 10/09/2024 | 4.93 | 4.94 | 4.69 | 4.76 | 958,925 | |
| 10/08/2024 | 4.87 | 5.10 | 4.86 | 4.92 | 959,250 | |
| 10/07/2024 | 4.93 | 4.96 | 4.78 | 4.85 | 517,808 | |
| 10/04/2024 | 4.79 | 4.96 | 4.69 | 4.95 | 1,025,946 | |
| 10/03/2024 | 4.75 | 4.80 | 4.60 | 4.68 | 1,422,331 | |
| 10/02/2024 | 4.73 | 4.88 | 4.64 | 4.79 | 918,672 | |
| 10/01/2024 | 4.98 | 4.98 | 4.75 | 4.76 | 1,407,420 | |
| 09/30/2024 | 4.76 | 5.20 | 4.74 | 4.98 | 2,442,621 | |
| 09/27/2024 | 5.13 | 5.18 | 4.54 | 4.72 | 2,659,147 | |
| 09/26/2024 | 4.96 | 5.07 | 4.89 | 5.00 | 976,026 | |
| 09/25/2024 | 5.01 | 5.10 | 4.82 | 4.86 | 1,102,090 | |
| 09/24/2024 | 4.93 | 5.08 | 4.89 | 5.04 | 899,004 | |
| 09/23/2024 | 5.15 | 5.16 | 4.73 | 4.88 | 1,314,613 | |
| 09/20/2024 | 5.20 | 5.29 | 5.06 | 5.09 | 2,990,265 | |
| 09/19/2024 | 5.14 | 5.20 | 4.95 | 5.20 | 1,164,165 | |
| 09/18/2024 | 4.86 | 5.11 | 4.76 | 4.95 | 1,134,572 | |
| 09/17/2024 | 5.02 | 5.07 | 4.79 | 4.79 | 1,016,773 | |
| 09/16/2024 | 4.84 | 5.02 | 4.75 | 4.96 | 1,086,904 | |
| 09/13/2024 | 4.60 | 4.84 | 4.60 | 4.84 | 1,079,164 | |
| 09/12/2024 | 4.94 | 4.94 | 4.51 | 4.55 | 1,507,242 | |
| 09/11/2024 | 4.67 | 4.98 | 4.56 | 4.95 | 1,416,836 | |
| 09/10/2024 | 4.69 | 4.75 | 4.45 | 4.61 | 1,125,234 | |
| 09/09/2024 | 4.24 | 4.72 | 4.20 | 4.69 | 1,296,821 | |
| 09/06/2024 | 4.23 | 4.27 | 4.10 | 4.18 | 625,548 | |
| 09/05/2024 | 4.26 | 4.33 | 4.18 | 4.23 | 480,824 | |
| 09/04/2024 | 4.15 | 4.46 | 4.13 | 4.24 | 742,743 | |
| 09/03/2024 | 4.43 | 4.58 | 4.16 | 4.19 | 1,352,329 | |
| 08/30/2024 | 4.45 | 4.54 | 4.33 | 4.53 | 893,242 | |
| 08/29/2024 | 4.58 | 4.59 | 4.40 | 4.40 | 702,206 | |
| 08/28/2024 | 4.59 | 4.63 | 4.43 | 4.55 | 650,814 |
About Aquestive Therapeutics Stock history
Aquestive Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aquestive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aquestive Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aquestive Therapeutics stock prices may prove useful in developing a viable investing in Aquestive Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 61.3 M | 37.4 M | |
| Net Loss | -49 M | -51.4 M |
Aquestive Therapeutics Quarterly Net Working Capital |
|
Aquestive Therapeutics Stock Technical Analysis
Aquestive Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Aquestive Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aquestive Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aquestive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aquestive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0482 | |||
| Jensen Alpha | 0.0408 | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | 0.032 | |||
| Treynor Ratio | 0.1052 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Aquestive Stock Analysis
When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.